Department of Genetics, Yale University School of Medicine, New Haven, CT 06510.
Hansjörg Wyss Department of Plastic Surgery, New York University Langone Medical Center, New York, NY 10016.
Proc Natl Acad Sci U S A. 2019 Jul 23;116(30):15116-15121. doi: 10.1073/pnas.1902041116. Epub 2019 Jul 10.
Craniosynostosis (CS) is a frequent congenital anomaly featuring the premature fusion of 1 or more sutures of the cranial vault. Syndromic cases, featuring additional congenital anomalies, make up 15% of CS. While many genes underlying syndromic CS have been identified, the cause of many syndromic cases remains unknown. We performed exome sequencing of 12 syndromic CS cases and their parents, in whom previous genetic evaluations were unrevealing. Damaging de novo or transmitted loss of function (LOF) mutations were found in 8 genes that are highly intolerant to LOF mutation ( = 4.0 × 10); additionally, a rare damaging mutation in , which has a lower level of intolerance, was identified. Four probands had rare damaging mutations (2 de novo) in , a transcription factor that orchestrates neural crest cell migration and differentiation; this mutation burden is highly significant ( = 8.2 × 10). Three probands had rare damaging mutations in , , or , which function in the Hedgehog, BMP, and Wnt signaling pathways; other genes in these pathways have previously been implicated in syndromic CS. Similarly, damaging de novo mutations were identified in genes encoding the chromatin modifier , and , encoding catenin α-1. These findings establish as a CS gene, have implications for assessing risk to subsequent children in these families, and provide evidence implicating other genes in syndromic CS. This high yield indicates the value of performing exome sequencing of syndromic CS patients when sequencing of known disease loci is unrevealing.
颅缝早闭(CS)是一种常见的先天性异常,其特征是颅盖的 1 个或多个缝过早融合。伴有其他先天性异常的综合征病例占 CS 的 15%。虽然已经确定了许多综合征性 CS 相关的基因,但许多综合征性病例的病因仍然未知。我们对 12 例综合征性 CS 患者及其父母进行了外显子组测序,这些患者之前的基因评估没有发现异常。在 8 个对 LOF 突变高度耐受的基因中发现了新生或传递的破坏性 LOF 突变(= 4.0×10);此外,还鉴定出 基因中的罕见有害突变,该基因的耐受水平较低。4 名先证者在 基因中存在罕见的破坏性突变(2 个新生突变),该基因是协调神经嵴细胞迁移和分化的转录因子;这种突变负担具有高度显著性(= 8.2×10)。3 名先证者在 、 或 基因中存在罕见的破坏性突变,这些基因在 Hedgehog、BMP 和 Wnt 信号通路中发挥作用;这些通路中的其他基因以前与综合征性 CS 有关。同样,在编码染色质修饰因子的基因 和编码连接蛋白α-1的基因 中也发现了新生的破坏性突变。这些发现确立了 为 CS 基因,对评估这些家庭中随后孩子的风险具有重要意义,并为其他基因参与综合征性 CS 提供了证据。这些高发现率表明,在外显子组测序未能揭示已知疾病基因座时,对综合征性 CS 患者进行外显子组测序具有重要价值。